We are international

Call the IMF Hotline. We are here for you. The IMF Office is open from 9:00 - 5:00 PT on Monday-Friday.

If you have a question, call the IMF Hotline at (800) 452-CURE (800-452-2873) in the US and Canada. The hotline is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
    next      view all

IMF at Chinese Myeloma Working Group Annual Meeting
The IMF's Chinese Myeloma Working Group (CMWG) held its annual meeting from April 9-13th in Hangzhou, China. The IMF's Asia Pacific team members, President Susie Novis, and Chairman Dr. Brian Durie traveled to China to participate in the meetings and activities. A highlight was a patient seminar held at Zhejiang University 1st Affiliated Hospital in Hangzhou, which was attended by approximately 200 patients and family members. During the seminar, Dr. Durie answered patient questions (with the help of a translator) for over an hour. Click HERE to read more about the meetings and patient seminar, which Dr. Durie calls "an amazing, heartwarming, and heart-wrenching program" in his blog post.

IMF's Nurse Leadership Board to Host Satellite Symposium at International Nursing Meeting
The IMF's Nurse Leadership Board (NLB) will host a satellite symposium during the Oncology Nursing Society's (ONS) 39th Annual Congress in Anaheim, California on May 1st. Leading myeloma nurses will discuss the best practices, cutting-edge research, and their own personal experiences with myeloma patients in an exciting and informative presentation. Presenters will discuss therapy combinations, newly approved myeloma drugs, specific cases (such as smoldering versus relapsed/refractory myeloma), and nursing management of patients. This event is one example of the NLB's exceptional work to bring expert myeloma advice to nurses in all communities. Click HERE for the event's agenda and/or to register.

Register now for the May 8 "Living Well with Myeloma" Teleconference!
The IMF's popular "Living Well with Myeloma" teleconference series returns on May 8th, with "Stopping to Breathe While Moving Forward." IMF Nurse Leadership Board Member Beth Faiman, PhDc, MSN, APRN-BC, AOCN, Certified Nurse Practitioner at the Cleveland Clinic, will lead the discussion and Q&A. The discussion will focus on the benefits of rest, relaxation, exercise, and nutrition for long-term management of multiple myeloma. Click HERE to register for the free teleconference, which will be held on Thursday, May 8th at 7 pm ET/ 4 pm PT.

Minimal Residual Disease (MRD) Marches to Front Line of Myeloma Research
The IMF's signature Black Swan Research Initiative® and IMF Chairman Dr. Brian Durie were featured this week in TargetedOnc.com, an online publication aimed at oncologists that focuses on the next stage of cancer development and cutting-edge therapies. "Minimal Residual Disease (MRD) Marches to Front Line of Myeloma Research" takes a comprehensive look at the increasingly important role MRD testing will play in future myeloma treatment and forging the pathway to a cure.

The International Myeloma Foundation Applauds Wisconsin Gov. Scott Walker for Signing SB 300 (The Cancer Treatment Fairness Act) into Law

Today in Milwaukee cancer patient advocates, including myeloma Support Group members Linda Chowa and Mary Sandberg, at right, looked on as Wisconsin Governor Scott Walker signed the Cancer Treatment Fairness Act (SB 300) into law, making Wisconsin the 30th state to enact anticancer drug parity legislation. "This bill shows that our voices do indeed make a difference, because SB 300 was on its deathbed just three weeks ago, and today it is law," said Sue Enright, Midwest Director of Support Groups for the International Myeloma Foundation. "Thank you to every patient, family member, friend, healthcare professional and advocate who relentlessly stood with us throughout this long journey, and to our Wisconsin legislators who voted in favor of the bill." 

Black Swan, Salamanca, and the FDA: A Highly Sensitive New Myeloma Test Debuts
A significant event in the evolution of the IMF's Black Swan Research Initiative® occurred this past weekend in Salamanca, Spain. On March 21-22, the IMF-EuroFlow Workshop focused on a breakthrough in the standardized detection of minimal residual disease (MRD) in myeloma using a new automated and highly sensitive flow cytometry technique. "More than 70 participants from 13 countries gathered to learn the exciting details," writes Dr. Brian Durie, IMF Chairman and Co-Founder, in this week's blog.

Congressman Brian Higgins Recognizes March as National Multiple Myeloma Awareness Month on House Floor

Congressman Brian Higgins (NY-26), a member of the House Cancer Caucus, spoke on the House Floor to recognize National Multiple Myeloma Awareness Month and to advocate for increased funding for medical research and passage of H.R. 1801, the Cancer Drug Coverage Parity Act

Jamaica Support Group spreading Myeloma Awareness on the radio
Monica Taylor, Jamaica MM Support Group leader, spreads Myeloma Awareness in an interview by Sharon Duffus-Grant of TBC Radio, Kingston, Jamaica. The interview was aired on Friday March 21.

The International Myeloma Foundation Secures Congressional Resolution Recognizing March 2014 as “National Multiple Myeloma Awareness Month”

The New Normal: Life After the Diagnosis
Palm Coast Florida couple Arnie and Maxine Levine shares how they have adapted their lifestyle to deal with living with Multiple Myeloma in an uplifting news article published in the Palm Coast Observer.

    next      view all